By Dr. Lei Deng
University of Washington & Fred Hutch
Watch Dr. Lei Deng’s overview of the KEYNOTE-671 and NADIM II trials, with important implications for non small cell lung cancer treatment!
Overview of KEYNOTE-671 & NADIM II
Latest from Blog
On August 28, 2023, the U.S. Food and Drug Administration approved luspatercept-aamt (Reblozyl) for the treatment of anemia
By Akshat Jain MD, MPH Hematology Oncology and Cellular Therapy Faculty Department of Pediatrics & Clinical
By Dr. Anish Shah Bronx-Lebanon Hospital On August 14, 2023, the U.S. Food and Drug
By Dr. Anish Shah Bronx-Lebanon Hospital On August 14, 2023, the U.S. Food and Drug
By Dr. Anish Shah Bronx Lebanon Hospital On August 11, 2023, the U.S. Food and